Aletha Maybank, MD, MPH recently joined the AMA in April 2019 as their inaugural Chief Health Equity Officer and Vice President. Her role is to embed health equity in all the work of the AMA and to launch a Center for Health Equity.
Prior to this in 2014, Dr. Maybank became an Associate Commissioner, and later a Deputy Commissioner, and lunched the Center for Health Equity, a new division in the NYC Department of Health and Mental Hygiene geared toward strengthening and amplifying the Health Department’s work in ending health inequities. Under her leadership, and in a short amount of time, the health department made great strides in transforming the culture and public health practice by embedding health equity in the health department’s work. This work has been recognized and adapted by other City agencies and has captured the attention of the CDC and WHO.
She also teaches medical and public health students on topics related to health inequities, public health leadership and management, physician advocacy, and community organizing health. Currently, Dr. Maybank serves as President of the Empire State Medical Association, the NYS affiliate of the National Medical Association. In 2012, she co-founded “We Are Doc McStuffins,” a movement created by African-American female physicians who are inspired by the Disney Junior character, Doc McStuffins.
Dr. Maybank holds a BA from Johns Hopkins University, an MD from Temple University School of Medicine, and an MPH from Columbia University Mailman School of Public Health. She is a pediatrician and board certified in Preventive Medicine and Public Health.
Lunch Plenary:
A Commitment to Advance Health Equity
State Efforts to Ban or Enforce COVID-19 Vaccine Mandates and Passports
/in COVID-19 State Action Center Featured News Home, Maps COVID-19, Featured Policy Home, Health Equity, Population Health, Relief and Recovery, Social Determinants of Health, Vaccines /by NASHP Staff and Ella RothVaccinating Children and Youth against COVID-19: Washington, DC’s Approach
/in COVID-19 State Action Center, Policy District Of Columbia Blogs, Featured News Home Back to School, Immunization, Maternal, Child, and Adolescent Health, Vaccines /by Michelle FiscusHow States Are Adapting COVID-19 Vaccination Strategies for Children under 5
/in COVID-19 State Action Center, Policy Blogs, Featured News Home COVID-19, Vaccines /by Michelle Fiscus, Katie Greene and Ella RothState Strategies to Increase COVID-19 Vaccination Rates in Children
/in COVID-19 Relief and Recovery Resource Center Blogs, Featured News Home Back to School, COVID-19, Relief and Recovery, Vaccines /by Michelle Fiscus and Rebecca CooperCOVID-19 vaccines have been available for children ages 5-11 since October 29, 2021. As of March 16, 2022, the Centers for Disease Control and Prevention (CDC) reports that just one-third (33%) of children in this age group have received their first vaccine dose, with vaccination rates varying widely by state. Just twenty-six percent of 5–11-year-olds […]
State Strategies to Improve HPV Vaccine Uptake in Pre-Teens and Adolescents
/in COVID-19 Relief and Recovery Resource Center Featured News Home, Reports Vaccines /by Rebecca Cooper, Ella Roth and Sandra WilknissStrategies to Increase COVID-19 Vaccination Rates in Medicaid Enrollees: Considerations for State Leaders
/in COVID-19 Relief and Recovery Resource Center Featured News Home, Reports COVID-19, Relief and Recovery, Vaccines /by NASHP StaffChampioning Health Equity
/in Health Equity Featured News Home, Reports COVID-19, Equity, Health Equity, Relief and Recovery, Vaccines /by NASHP StaffAchieving Progress Toward Health Equity Using Race and Ethnicity Data: State Strategies and Lessons Learned
/in Health Equity Featured News Home, Reports COVID-19, Equity, Health Equity, Relief and Recovery, Vaccines /by NASHP StaffStates Take Action on Vaccine Mandates in Schools
/in COVID-19 State Action Center Blogs, Featured News Home Back to School, COVID-19, Vaccines /by Zack GouldChildren and COVID-19: Strategies and Partnerships for Vaccination
/in Policy Webinars COVID-19, Relief and Recovery, Vaccines /by NASHP Staff